Participant flow

Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST) · Source last updated 2018-03-14

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   All subjects received in tablet form imatinib (STI571) 400 mg once daily.

   id

   FG000

   title

   Imatinib

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         15

      type

      Adverse Event

   2. reasons

      1. group Id

         FG000

         num Subjects

         2

      type

      Death

   3. reasons

      1. group Id

         FG000

         num Subjects

         19

      type

      Withdrawal by Subject

   4. reasons

      1. group Id

         FG000

         num Subjects

         3

      type

      Lost to Follow-up

   5. reasons

      1. group Id

         FG000

         num Subjects

         1

      type

      Administrative problems

   6. reasons

      1. group Id

         FG000

         num Subjects

         1

      type

      Disease progression/relapse

   7. reasons

      1. group Id

         FG000

         num Subjects

         4

      type

      Protocol Violation

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         91

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         91

      type

      Safety Set

   3. achievements

      1. group Id

         FG000

         num Subjects

         91

      type

      Full Analysis Set (FAS)

   4. achievements

      1. group Id

         FG000

         num Subjects

         46

      type

      COMPLETED

   5. achievements

      1. group Id

         FG000

         num Subjects

         45

      type

      NOT COMPLETED

   title

   Treatment Period

2. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         1

      type

      Death

   2. reasons

      1. group Id

         FG000

         num Subjects

         1

      type

      Withdrawal by Subject

   3. reasons

      1. group Id

         FG000

         num Subjects

         5

      type

      Lost to Follow-up

   4. reasons

      1. group Id

         FG000

         num Subjects

         4

      type

      Administrative problems

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         68

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         57

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         11

      type

      NOT COMPLETED

   title

   Post Treatment After Survival Follow-up

pre Assignment Details

Total of 113 subjects were screened and 91 were enrolled..

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice